Editorial board

Mark Glassy UC San Diego, USA

Robert M. Anthony Massachusetts General Hospital, USA
Dimitrios P. Bogdanos University of Thessaly, Greece
Dennis R. Burton The Scripps Research Institute, USA
Paul Carter Genentech, Inc., USA
Ricard Cervera University of Barcelona, Spain
Stefan Dubel Technische Universitat Braunschweig, Germany
Gilad Halpert Zabludowicz Center for Autoimmune Diseases, Israel
Michael Hust Technische Universitat Braunschweig, Germany
Angray S. Kang Queen Mary University of London, UK
Renate Kunert Universität für Bodenkultur, Austria
Alois B. Lang GeNeuro SA, Switzerland
James W. Larrick Regenerative Sciences Institute, USA
Julian Ma St. George's University of London, UK
James D. Marks San Francisco General Hospital, USA
Sherie Morrison UCLA, USA
David Naor The Hebrew University of Jerusalem, Israel
Paul W. H. I. Parren Lava Therapeutics, The Netherlands
Carlo Perricone University of Perugia, Italy
Andreas A. Plückthun University of Zurich, Switzerland
Matthew D. Scharff The Albert Einstein College of Medicine, USA
Yehuda Shoenfeld Sheba Medical Center, Israel
Sachdev Sidhu University of Waterloo, Canada
Lim Theam Soon Universiti Sains Malaysia, Malaysia
Jamie B. Sprangler Johns Hopkins University, USA
Leonidas Stamatatos Fred Hutchinson Cancer Research Center, USA
Michael Steinitz The Hebrew University, Israel
Mohammad Taheri Jena University Hospital, Germany
Jean-Luc Teillaud French Institute of Health and Medical Research, France
Louis M. Weiner Georgetown Lombardi Comprehensive Cancer Center, USA
Gregory Winter Trinity College, UK
K. Dane Wittrup Massachusetts Institute of Technology, USA
Susan Zolla-Pazner Icahn School of Medicine at Mount Sinai, New York, NY, USA